Organon & Co. (OGN)
13.64
+0.01
(+0.07%)
USD |
NYSE |
Sep 11, 16:00
13.64
0.00 (0.00%)
After-Hours: 20:00
Organon Price to Book Value : 3.561 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.561 |
| September 10, 2026 | 3.558 |
| September 09, 2026 | 3.568 |
| September 08, 2026 | 3.589 |
| September 04, 2026 | 3.597 |
| September 03, 2026 | 3.595 |
| September 02, 2026 | 3.595 |
| September 01, 2026 | 3.592 |
| August 31, 2026 | 3.592 |
| August 28, 2026 | 3.592 |
| August 27, 2026 | 3.592 |
| August 26, 2026 | 3.595 |
| August 25, 2026 | 3.589 |
| August 24, 2026 | 3.589 |
| August 21, 2026 | 3.589 |
| August 20, 2026 | 3.587 |
| August 19, 2026 | 3.584 |
| August 18, 2026 | 3.571 |
| August 17, 2026 | 3.576 |
| August 14, 2026 | 3.582 |
| August 13, 2026 | 3.582 |
| August 12, 2026 | 3.566 |
| August 11, 2026 | 3.563 |
| August 10, 2026 | 3.555 |
| August 07, 2026 | 3.550 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.537 |
| August 05, 2026 | 3.542 |
| August 04, 2026 | 3.540 |
| August 03, 2026 | 3.540 |
| July 31, 2026 | 3.537 |
| July 30, 2026 | 3.537 |
| July 29, 2026 | 3.534 |
| July 28, 2026 | 3.529 |
| July 27, 2026 | 3.534 |
| July 24, 2026 | 3.529 |
| July 23, 2026 | 3.540 |
| July 22, 2026 | 3.529 |
| July 21, 2026 | 3.527 |
| July 20, 2026 | 3.522 |
| July 17, 2026 | 3.529 |
| July 16, 2026 | 3.522 |
| July 15, 2026 | 3.522 |
| July 14, 2026 | 3.524 |
| July 13, 2026 | 3.524 |
| July 10, 2026 | 3.529 |
| July 09, 2026 | 3.522 |
| July 08, 2026 | 3.516 |
| July 07, 2026 | 3.527 |
| July 06, 2026 | 3.540 |
| July 02, 2026 | 3.537 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.473 |
| Eli Lilly & Co. | 31.01 |
| Pfizer Inc. | 1.854 |
| Bristol Myers Squibb Co. | 5.825 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 7.541 |
Price to Book Value Related Metrics
| PE Ratio | 17.47 |
| PS Ratio | 0.5867 |
| Price to Free Cash Flow | 6.442 |
| Price | 13.64 |
| Earnings Yield | 5.72% |
| Market Cap | 3.582B |
| Operating PE Ratio | 3.023 |
| Normalized PE Ratio | 9.013 |